Table 1 Baseline characteristics and procedures, complications, and outcomes during ICU stay among patients requiring neurocritical care.

From: Epidemiology and disease burden of patients requiring neurocritical care: a Brazilian multicentre cohort study

Characteristics

n = 1194

Baseline

 Age, mean ± SD, years

58.9 ± 19.4

 Male sex, n (%)

618 (51.8)

 Transportation to the hospitala, n (%)

  Critical care ambulance

376 (31.5)

  Ambulance without critical care service

91 (7.6)

  Family members

355 (29.7)

  Self-driven

370 (31.0)

 Coverage of hospitalization costs, n (%)

  Public health insurance

591 (49.5)

  Complementary or private insurance

603 (50.5)

 Type of ICU admission, n (%)

  Elective

317 (26.6)

  Emergency

877 (73.4)

 Location before transfer to the ICU, n (%)

  Emergency department

567 (47.5)

  Operating room

428 (35.8)

  Hospital ward

81 (6.8)

  Other

118 (9.9)

 Severity scores on ICU admission

  Glasgow Coma Scale, Median (IQR)

14 (9–15)

  APACHE II, median (IQR)

11 (7–17)

  SAPS IIIb, median (IQR)

44 (33–56)

  SOFAc, median (IQR)

2 (1–6)

 Comorbidities

  Hypertension, n (%)

603 (50.5)

  Cardiopathy, n (%)

177 (14.8)

  Chronic obstructive pulmonary disease, n (%)

51 (4.3)

  Renal disease, n (%)

83 (7.0)

  Diabetes mellitus, n (%)

218 (18.3)

  Extracranial neoplasia, n (%)

89 (7.5)

 Primary neurological diagnoses, n (%)

  Postoperative care of elective neurosurgery

317 (25.6)

  Traumatic brain injury

218 (18,3)

  Ischaemic stroke

211 (17.7)

  Encephalopathy

155 (13)

  Seizures

91 (7.6)

  Intracerebral haemorrhage

77 (6.4)

  Subarachnoid haemorrhage

70 (5.9)

  Central nervous system infection

25 (2.1)

  Spinal cord injury

19 (1.6)

  Neuromuscular disease

11 (0.9)

 Potential secondary injuries (Hs) at ICU admission

  Hypotension (MAP < 65 mmHg or SBP < 90 mmHg), n (%)

267 (22.4)

  Hypoxemia (PaO2 < 60 mmHg or são2 < 90% or SpO2 < 90%), n (%)

72 (6.0)

  Hyperthermia (body temperature > 37.5°C), n (%)

126 (10.6)

  Hypercapnia (PaCO2 > 45 mmHg ou RR < 8 ipm), n (%)

115 (9.6)

  Hypocapnia (PaCO2 < 35 mmHg), n (%)

213 (19.3)

  Hypoglycaemia (venous or capillary glucose values < 60 mg/dL) n (%)

32 (2.7)

  Hyponatremia (sodium < 135 mmHg), n (%)

200 (16.8)

  Hypothermia (body temperature < 35°C), n (%)

121 (10.1)

  Intracranial hypertension (intracranial pressure > 25 mmHg), n (%)

89 (7.5)

  Clinical evidence of herniation, n (%)

77 (6.4)

  Number of Hs, n (%)

 

    Zero

500 (41.9)

    One

318 (26.6)

    Two

203 (17.0)

    Three or more

173 (14.5)

 Imaging tests performed on the first day of ICU admission

  Computed tomography of the head, n (%)

931 (78)

  Magnetic resonance of the head, n (%)

208 (17.4)

  Cerebral arteriogram, n (%)

87 (7.3)

 Procedures performed during the ICU stay

  Urgent neurosurgery, n (%)

199 (16.7)

  Placement of an external ventricular drain, n (%)

84 (7.0)

  Invasive mechanical ventilation, n (%)

460 (38.5)

  Tracheostomy, n (%of patients placed on invasive mechanical ventilation)

146 (31.7)

  Noninvasive mechanical ventilation, n (%)

77 (6.4)

  Vasoactive drug—vasopressor, n (%)

358 (25.0)

  Vasoactive drug—vasodilator, n (%)

82 (6.9)

  Renal replacement therapy, n (%)

65 (5.4)

  Intracranial pressure monitoring—intraparenchymal, n (%)

55 (4.6)

  Intracranial pressure monitoring—intraventricular, n (%)

40 (3.3)

  Electroencephalographic monitoring, n (%)

102 (8.5)

  Intracranial Doppler monitoring, n (%)

37 (3.1)

  Brain tissue oxygen pressure monitoring, n (%)

4 (0.3)

 Complications

  Pneumonia, n (%)

203 (17)

  Urinary tract infection, n (%)

43 (3.6)

  Catheter-related infection, n (%)

35 (2.9)

  Primary bloodstream infection, n (%)

27 (2.3)

  Neurological infection, n (%)

23 (1.9)

  Wound infection, n (%)

15 (1.2)

  Clostridium associated diarrhoea, n (%)

2 (0.2)

  Renal failure, n (%)

100 (8.4)

  Acute respiratory distress syndrome, n (%)

38 (3.2)

  Gastrointestinal bleeding, n (%)

15 (1.3)

  Intracranial hypertension, n (%)

129 (10.8)

 Outcome until the 30th study day, n (%)

  ICU discharge

832 (69.7)

  Transfer to another hospital

22 (1.8)

  Continued hospitalization on ICU

152 (12.7)

  Mortality

188 (15.7)

  Brain deathd, n (%)

48 (25.5)

 mRS on the day of the ICU outcome or until the 30th study daye, n (%)

  0. No symptoms at all

283 (23.7)

  1. No significant disability despite symptoms; able to carry out all usual duties and activities

201 (16.9)

  2. Slight disability; unable to carry out all previous activities, but able to look after own affair without assistance

121 (10.2)

  3. Moderate disability; requiring some help (e.g., with shopping/managing affairs) but able to walk without assistance

100 (8.4)

  4. Moderately severe disability; unable to walk without assistance and unable to attend to own bodily needs without assistance

154 (12.9)

  5. Severe disability; bedridden, incontinent, and requiring constant nursing care and attention

140 (11.8)

  6 Dead

188 (15.8)

Unfavourable outcome (mRS score 4, 5, or 6)f, n (%)

482 (40.6)

Length of ICU stay until the 30th study day, Median (IQR)

5 (3–16)

  1. APACHE II acute physiology and chronic health evaluation, ICU intensive care unit, IQR interquartile range, MAP mean arterial pressure, mRS modified Rankin Scale, n absolute frequency, PaCO2 partial arterial carbon dioxide pressure, PaO2 partial arterial oxygen pressure, RR respiratory rate, SaO2 arterial oxygen saturation, SAPS III simplified acute physiology score III, SBP systolic blood pressure, SD standard deviation, SOFA sequential organ failure assessment, SpO2 peripheral oxygen saturation, % percentage within column.
  2. a2 missing data.
  3. b35 missing data.
  4. c54 missing data.
  5. dPercentage calculation considering the 188 deaths from neurological causes in the intensive care unit. In this classification, only patients who had a closed brain death protocol were considered.
  6. e7 missing data.